GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroScientific Corp (HKSE:02172) » Definitions » EBIT

MicroPort NeuroScientific (HKSE:02172) EBIT : HK$289.7 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroScientific EBIT?

MicroPort NeuroScientific's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was HK$185.4 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$289.7 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. MicroPort NeuroScientific's annualized ROC % for the quarter that ended in Jun. 2024 was 32.29%. MicroPort NeuroScientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 116.52%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. MicroPort NeuroScientific's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 5.60%.


MicroPort NeuroScientific EBIT Historical Data

The historical data trend for MicroPort NeuroScientific's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroScientific EBIT Chart

MicroPort NeuroScientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
60.12 66.11 94.41 106.03 181.03

MicroPort NeuroScientific Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only 0.80 105.27 76.75 104.28 185.45

Competitive Comparison of MicroPort NeuroScientific's EBIT

For the Medical Devices subindustry, MicroPort NeuroScientific's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort NeuroScientific's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroScientific's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MicroPort NeuroScientific's EV-to-EBIT falls into.



MicroPort NeuroScientific EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$289.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort NeuroScientific  (HKSE:02172) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

MicroPort NeuroScientific's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=361.574 * ( 1 - 18.06% )/( (886.204 + 948.703)/ 2 )
=296.2737356/917.4535
=32.29 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2144.508 - 159.407 - ( 1098.897 - max(0, 272.623 - 1457.508+1098.897))
=886.204

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2239.123 - 217.187 - ( 1073.233 - max(0, 308.904 - 1583.901+1073.233))
=948.703

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

MicroPort NeuroScientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=370.89/( ( (179.053 + max(86.532, 0)) + (155.984 + max(215.035, 0)) )/ 2 )
=370.89/( ( 265.585 + 371.019 )/ 2 )
=370.89/318.302
=116.52 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(11.555 + 219.809 + 101.774) - (159.407 + 0 + 87.199)
=86.532

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(167.032 + 183.672 + 148.467) - (217.187 + 0 + 66.949)
=215.035

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

MicroPort NeuroScientific's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=289.725/5172.340
=5.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort NeuroScientific EBIT Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroScientific's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort NeuroScientific Business Description

Traded in Other Exchanges
N/A
Address
No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN
MicroPort NeuroScientific Corp formerly MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.
Executives
Microport Scientific Corporation
Hu Yibin
Biolink Biomedical Ltd. 2201 Interest of corporation controlled by you
Blossom Vision Limited 2201 Interest of corporation controlled by you
Lion Fish Limited 2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited 2301 Trustee
Thriving Hope Limited 2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership 2201 Interest of corporation controlled by you
Biolink Limited 2101 Beneficial owner
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroScientific Headlines

No Headlines